Close Menu

NEW YORK ─ AnchorDx said on Thursday that it has entered into a multi-year collaboration with the Lung Cancer Initiative at Johnson & Johnson to conduct a four-year study to enable the early detection and diagnosis of lung cancer. Specifically, the agreement is with Johnson & Johnson (China) Investment.

Investigators will enroll and track the progress of more than 3,000 patients with pulmonary nodules identified by computed tomography scanning, according to AnchorDx, a developer of next-generation sequencing-based early cancer detection and disease monitoring tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.